Eris Lifesciences Limited (BOM:540596)
1,281.10
+29.70 (2.37%)
At close: Feb 19, 2025
Eris Lifesciences Revenue
Eris Lifesciences had revenue of 7.22B INR in the quarter ending December 31, 2024, with 49.36% growth. This brings the company's revenue in the last twelve months to 27.24B, up 47.99% year-over-year. In the fiscal year ending March 31, 2024, Eris Lifesciences had annual revenue of 19.91B with 19.83% growth.
Revenue (ttm)
27.24B
Revenue Growth
+47.99%
P/S Ratio
n/a
Revenue / Employee
7.52M
Employees
3,620
Market Cap
174.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 19.91B | 3.29B | 19.83% |
Mar 31, 2023 | 16.62B | 3.36B | 25.31% |
Mar 31, 2022 | 13.26B | 1.34B | 11.20% |
Mar 31, 2021 | 11.93B | 1.34B | 12.71% |
Mar 31, 2020 | 10.58B | 909.81M | 9.41% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,702.59B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 1,755.26B |
Infosys | 1,635.60B |
State Bank of India | 3,409.52B |
Hindustan Unilever | 626.61B |